• Blog
  • G Protein Coupled Receptors (GPCRs) Market Report

    G Protein Coupled Receptors (GPCRs) Market Report

    G Protein Coupled Receptors (GPCRs) Market Report
    Report code - SRHL221 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global G-Protein Coupled Receptors (GPCRs) Market, Dynamics, Market Analysis
    See more...

    Impact of COVID-19 on G Protein Coupled Receptors (GPCRs) Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on G Protein Coupled Receptors (GPCRs) Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global G-Protein Coupled Receptors (GPCRs) Market is estimated to grow from USD 2.9 billion in 2020 to USD 4.2 billion by 2026 at a healthy CAGR of 6.7% during the forecast period.

    Figure: Global G-Protein Coupled Receptors (GPCRs) Market Size, 2020-2026 (USD Billion)

    G-Protein-Coupled-Receptor-Market-Forecast

    Wish to get a free sample report? Click here.

    What is G-Protein Coupled Receptor?

    G-protein coupled receptor, also known as a transmembrane receptor or heptahelical receptor is the most diverse group of membrane receptors in eukaryotes. It is located in the cell membrane which binds extracellular substances and transmits the signals from these substances to intracellular receptors which are called G-protein.

    Key Players

    Key players operating in the global G-Protein Coupled Receptors (GPCRs) market are-

    • Thermo Fisher Scientific (The U.S),
    • Eurofins Scientific (Luxembourg),
    • Abcam plc (UK),
    • Enzo Biochem Inc. (The U.S),
    • Merck KGaA (Germany),
    • QIAGEN (Germany),
    • Becton-Dickinson and Company (The U.S),
    • Promega Corporation (The U.S),
    • WuXi AppTec (The U.S). and
    • PerkinElmer Inc. (UK).

    Market Dynamics

    The global market growth is primarily driven by the increasing prevalence of diseases such as cancer, cardiovascular and respiratory issues.

    • The presence of various approved drugs and drugs that are under clinical studies which target these receptors is likely to drive the growth of the G-protein-coupled receptors market at a significant rate.
    • Furthermore, increasing spending on research and development activities in drug discovery and development is likely to create lucrative growth opportunities for the players operating in the GPCRs market over the forecast period.

    Segment Analysis

    Application Trends

    Based on application, the market has been divided into cancer research, central nervous system (CNS) research, metabolic research, cardiovascular research, and respiratory research, and others. The cancer research segment accounted for the substantial market share in 2020 owing to its widespread use in the detection of tumour angiogenesis through GPCR assays.

    Regional Trends

    The market in North America accounted for the largest share in 2020 owing to rising incidences of cancer, approved GPCR based drugs, and increased spending on new drug discovery and development, particularly in the U.S.

    The market in the Asia-Pacific region is projected to register a healthy growth rate on account of increasing consumer awareness and high spending on R&D activities for drug development by the government in countries such as India and China.

    COVID-19 Impact on Global G-Protein Coupled Receptors (GPCRs) Market

    The Covid-19 outbreak impacted the growth of the G-protein coupled receptor market positively as based on the pathological findings of coronavirus infected patients, it has been observed that GPR4 plays an essential role in Covid-19 pathophysiology and is a potential therapeutic target for treating Covid-19 infected patients. It can be exploited to mitigate the vessel hyper-permeability, hyper-inflammatory response, exudate formation, pulmonary edema, vascular thromboembolism, and tissue injury that is associated with Covid-19.

    Critical queries answered in this report -

    • What are the key trends in the global G-protein coupled receptors market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on global G-protein coupled receptors market?
    • What are the key strategies adopted by the major vendors to lead in the global G-protein coupled receptors market?
    • What is the market share of the top vendors?

    Wish to buy the full report? Click here.

    Target Audience

    Here is the list of the group of customers that the Global G-protein Coupled Receptor market hopes to have the greatest opportunity to convert-

    • G-protein coupled receptors distributors.
    • G-protein coupled receptors suppliers.
    • G-protein coupled receptors manufacturers.
    • Logistics organizations.
    • Government Bodies.

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The G-protein coupled receptors market is expected to witness an impressive growth of 6.7% CAGR in the foreseeable future.

    Thermo Fisher Scientific (The U.S), Eurofins Scientific (Luxembourg), Abcam plc (UK), Enzo Biochem Inc. (The U.S), Merck KGaA (Germany), QIAGEN (Germany), Becton-Dickinson and Company (The U.S), Promega Corporation (The U.S), WuXi AppTec (The U.S) and PerkinElmer Inc. (UK) are among the key players in the G-protein coupled receptors market.

    The G-protein coupled receptors market size is expected to reach USD 4.2 billion in the coming years.

    North America accounted for the largest share of the G-protein coupled receptors market in 2020.

    Increasing prevalence of diseases such as cancer, cardiovascular and respiratory issues, presence of various approved drugs and drugs that are under clinical studies which target these receptors, increasing spending on research and development activities in drug discovery and development are the factors driving the growth of G-protein coupled receptors market.

    G-protein coupled receptors distributors, G-protein coupled receptors suppliers, G-protein coupled receptors manufacturers, Logistics organizations, Government Bodies are the target audience in the G-protein coupled receptors market.

    •